v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 13,203 $ 7,772 $ 40,578 $ 27,339
General and administrative 8,413 9,211 31,083 25,092
Total operating expenses 21,616 16,983 71,661 52,431
Loss from operations (21,616) (16,983) (71,661) (52,431)
Other income (expense):        
Interest income, net 1,163 360 3,759 443
Foreign exchange (loss)/gain, net (439) 138 (244) 94
Change in fair value of 2022 USD Financing Warrants 3,020   (3,671)  
Other (expense)/income (51)   (51) 1
Total other income/(expense), net 3,693 498 (207) 538
Net loss (17,923) (16,485) (71,868) (51,893)
Other comprehensive loss:        
Gain/(loss) on foreign currency translation 415 (107) 150 (303)
Comprehensive loss $ (17,508) $ (16,592) $ (71,718) $ (52,196)
Net loss per common share, basic $ (0.45) $ (0.56) $ (1.85) $ (1.82)
Net loss per common share, diluted $ (0.45) $ (0.56) $ (1.85) $ (1.82)
Weighted-average common shares, basic 39,720,007 29,296,333 38,798,374 28,566,161
Weighted-average common shares, diluted 39,720,007 29,296,333 38,798,374 28,566,161

Source